financetom
Business
financetom
/
Business
/
Strategy Acquires 20,356 Bitcoin For $1.99 Billion, Boosts 2025 BTC Yield To 6.9%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Strategy Acquires 20,356 Bitcoin For $1.99 Billion, Boosts 2025 BTC Yield To 6.9%
Feb 24, 2025 7:14 AM

Strategy Incorporated announced it acquired 20,356 Bitcoin for approximately $1.99 billion at an average price of $97,514 per Bitcoin (CRYPTO: BTC) between Feb. 18 and Feb. 23, achieving a year-to-date BTC Yield of 6.9%.

What Happened: As of Feb. 23, the company holds 499,096 Bitcoin, purchased for an aggregate $33.1 billion at an average price of $66,357 per Bitcoin, according to a Securities and Exchange Commission filing.

The Bitcoin purchase was funded using proceeds from a $2.0 billion private offering of 0% convertible senior notes due 2030, completed on Feb. 21.

Net proceeds from the offering totaled $1.99 billion, with an option for initial purchasers to buy an additional $300 million in notes until Feb. 27.

"The bitcoin purchases were made using proceeds from the Convertible Notes Offering," the filing states, reflecting MicroStrategy's ( MSTR ) strategy of leveraging debt to expand its bitcoin holdings.

Also Read: Bybit Founder Confirms $1.4 Billion Ethereum Hack, Blames ‘Masked’ Transaction

Why It Matters: Strategy's BTC Yield, a key performance indicator measuring the percentage change in the ratio of bitcoin holdings to assumed diluted shares outstanding, reached 6.9% from Jan. 1 to Feb. 23.

The company also reported a BTC gain of 30,702 Bitcoin and a BTC gain of $2.9 billion, based on the market price of Bitcoin on Feb. 23.

"From January 1, 2025 to February 23, 2025, the Company's BTC Yield was 6.9%," the filing notes.

As of Feb. 23, Strategy's total Bitcoin holdings stood at 499,096, up from 447,470 at the end of 2024.

The company did not sell any shares of its class A common stock under its at-the-market equity offering program during the same period, focusing instead on debt-financed Bitcoin acquisitions.

Read Next:

Coinbase CEO Brian Armstrong Says SEC Has Agreed To End ‘Bogus’ Enforcement Case Without Penalties

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Foods' Fiscal Q3 Adjusted Earnings, Net Sales Increase; 2024 Guidance Updated
US Foods' Fiscal Q3 Adjusted Earnings, Net Sales Increase; 2024 Guidance Updated
Nov 9, 2024
07:38 AM EST, 11/07/2024 (MT Newswires) -- US Foods Holding ( USFD ) reported fiscal Q3 adjusted earnings Thursday of $0.85 per diluted share, up from $0.70 a year earlier. Analysts polled by Capital IQ expected $0.83. Net sales for the quarter ended Sept. 28 were $9.73 billion compared with $9.11 billion a year earlier. Analysts surveyed by Capital IQ...
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Nov 9, 2024
Nov 7 (Reuters) - Becton Dickinson ( BDX ) surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices. Medical technology firms such as Becton, Boston Scientific ( BSX ) and Abbott Laboratories ( ABT ) have been benefiting from robust demand for non-essential surgical procedures, especially among older patients. On an adjusted basis,...
Cameco Swings to Q3 Adjusted Loss, Revenue Increases
Cameco Swings to Q3 Adjusted Loss, Revenue Increases
Nov 9, 2024
07:38 AM EST, 11/07/2024 (MT Newswires) -- Cameco ( CCJ ) reported Thursday that it swung to a Q3 adjusted loss of 0.01 Canadian dollar ($0.007) per diluted share from an adjusted profit of CA$0.32 a year earlier. Analysts polled by Capital IQ expected CA$0.25. Revenue for the quarter ended Sept. 30 was CA$721 million, up from CA$575 million a...
BRIEF-Royalty Pharma To Acquire Royalty Interest In Geron'S RYTELO For $125 Mln
BRIEF-Royalty Pharma To Acquire Royalty Interest In Geron'S RYTELO For $125 Mln
Nov 9, 2024
Nov 7 (Reuters) - Geron Corp ( GERN ): * ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN GERON'S RYTELO FOR $125 MILLION * ROYALTY PHARMA PLC ( RPRX ) -DEAL INCREASES SYNTHETIC ROYALTY FUNDING TO $925 MILLION IN 2024 Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved